BACKGROUND: Active TB disease can destroy lung parenchyma leading to cavities. Immune responses that predispose or protect individuals from lung damage during TB are poorly defined. OBJECTIVE: To sample lung immune cells and assay bronchoalveolar lavage (BAL) cell cytokine production. DESIGN: Enrolled subjects (n = 73) had bilateral infiltrates and underwent BAL. RESULTS: All had sputum culture demonstrating Mycobacterium tuberculosis and 22/73 (30%) had cavities on their chest radiograph. Those with cavities at presentation had a higher percentage of polymorphonuclear neutrophils (PMN) in BAL as well as lower inducible protein (IP) 10 (P < 0.01) and interleukin (IL) 6 (P = 0.013) in BAL cell supernatants compared to those without cavities. There was no correlation between cavities and other BAL or serum cytokines. IP-10 was negatively associated with BAL PMN. IP-10 and IL-6 expression above median reduces the odds of cavities by 79% and 78% in logistic regression models. IP-10 and IL-6 clustered with interferon-gamma and tumour necrosis factor-alpha in a principal component analysis, while IL-4 clustered with PMN. CONCLUSION: Increasing IP-10 and IL-6 production by BAL cells is associated with non-cavitary TB in patients who present with radiographically advanced TB. IP-10 and IL-6 may reflect an effective T-helper 1 immune control pathway for TB, attenuating tuberculous lung destruction.
BACKGROUND:Active TB disease can destroy lung parenchyma leading to cavities. Immune responses that predispose or protect individuals from lung damage during TB are poorly defined. OBJECTIVE: To sample lung immune cells and assay bronchoalveolar lavage (BAL) cell cytokine production. DESIGN: Enrolled subjects (n = 73) had bilateral infiltrates and underwent BAL. RESULTS: All had sputum culture demonstrating Mycobacterium tuberculosis and 22/73 (30%) had cavities on their chest radiograph. Those with cavities at presentation had a higher percentage of polymorphonuclear neutrophils (PMN) in BAL as well as lower inducible protein (IP) 10 (P < 0.01) and interleukin (IL) 6 (P = 0.013) in BAL cell supernatants compared to those without cavities. There was no correlation between cavities and other BAL or serum cytokines. IP-10 was negatively associated with BAL PMN. IP-10 and IL-6 expression above median reduces the odds of cavities by 79% and 78% in logistic regression models. IP-10 and IL-6 clustered with interferon-gamma and tumour necrosis factor-alpha in a principal component analysis, while IL-4 clustered with PMN. CONCLUSION: Increasing IP-10 and IL-6 production by BAL cells is associated with non-cavitary TB in patients who present with radiographically advanced TB. IP-10 and IL-6 may reflect an effective T-helper 1 immune control pathway for TB, attenuating tuberculous lung destruction.
Authors: A Marchant; A Amedei; A Azzurri; J Vekemans; M Benagiano; C Tamburini; C Lienhardt; T Corrah; K P McAdam; S Romagnani; M M D'Elios; G Del Prete Journal: Am J Respir Cell Mol Biol Date: 2001-02 Impact factor: 6.914
Authors: Jennifer H Dufour; Michelle Dziejman; Michael T Liu; Josephine H Leung; Thomas E Lane; Andrew D Luster Journal: J Immunol Date: 2002-04-01 Impact factor: 5.422
Authors: J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun Journal: N Engl J Med Date: 2001-10-11 Impact factor: 91.245
Authors: V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808
Authors: Joshua R Bleharski; Huiying Li; Christoph Meinken; Thomas G Graeber; Maria-Teresa Ochoa; Masahiro Yamamura; Anne Burdick; Euzenir N Sarno; Manfred Wagner; Martin Röllinghoff; Thomas H Rea; Marco Colonna; Steffen Stenger; Barry R Bloom; David Eisenberg; Robert L Modlin Journal: Science Date: 2003-09-12 Impact factor: 47.728
Authors: Christian Lienhardt; Annalisa Azzurri; Amedeo Amedei; Katherine Fielding; Jackson Sillah; Oumou Y Sow; Boubacar Bah; Marisa Benagiano; Alimou Diallo; Roberto Manetti; Kebba Manneh; Per Gustafson; Steve Bennett; Mario M D'Elios; Keith McAdam; Gianfranco Del Prete Journal: Eur J Immunol Date: 2002-06 Impact factor: 5.532
Authors: Rany Condos; Bindu Raju; Antony Canova; Ben-Yang Zhao; Michael Weiden; William N Rom; Richard Pine Journal: Infect Immun Date: 2003-04 Impact factor: 3.441
Authors: Christian Herzmann; Martin Ernst; Christoph Lange; Steffen Stenger; Stefan H E Kaufmann; Norbert Reiling; Tom Schaberg; Lize van der Merwe; Jeroen Maertzdorf Journal: PLoS One Date: 2017-11-10 Impact factor: 3.240
Authors: Anna Cristina C Carvalho; Gustavo Amorim; Mayla G M Melo; Ana Karla A Silveira; Pedro H L Vargas; Adriana S R Moreira; Michael S Rocha; Alexandra B Souza; María B Arriaga; Mariana Araújo-Pereira; Marina C Figueiredo; Betina Durovni; José R Lapa-E-Silva; Solange Cavalcante; Valeria C Rolla; Timothy R Sterling; Marcelo Cordeiro-Santos; Bruno B Andrade; Elisangela C Silva; Afrânio L Kritski Journal: Front Immunol Date: 2021-07-02 Impact factor: 7.561